Details of the Drug Formulation (DFM)
| General Information of DFM (ID: F12658) | |||||
|---|---|---|---|---|---|
| Name |
Omega-3 acid ethyl ester 1000 mg capsule
|
||||
| Company |
Par Pharmaceutical
|
||||
| Active Pharmaceutical Ingredient (API) | Omega-3 acid ethyl ester |
API Info
 click to show the detail info of this API
|
|||
| Hypertriglyceridaemia | ICD-11: 5C80 | Approved | |||
| Drug Inactive Ingredient (DIGs) | |||||
| DIG ID | DIG Info | DIG Name | DIG Functional Class | ||
| E01VDF | DIG Info | Butyl alcohol | Flavoring agent ... | ||
| E06WYP | DIG Info | Glycerin | Antimicrobial preservative ... | ||
| E0HR5F | DIG Info | Soybean lecithin | Other agent | ||
| E05BSD | DIG Info | Titanium dioxide | Coating agent ... | ||
| E0H2SC | DIG Info | Water | Solvent | ||
| Full List of Biological Targets of DIG (DBTs) Regulated by DIG(s) in This DFM | ||||||
|---|---|---|---|---|---|---|
| Oxidoreductase (ORase) | ||||||
| DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
| Detailed Information |
DBT Info
click to show the detail info of this DBT
|
|||||
| Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
| Interacting DIG | Soybean lecithin | |||||
| Biological Activity | IC50 = 6.61 mg.mL-1 (tested by experiment) | [1] | ||||
| Tested Species | Homo sapiens (Human) | |||||
| UniProt ID | CP3A4_HUMAN | |||||
| References | |||||
|---|---|---|---|---|---|
| 1 | Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration. Eur J Pharm Biopharm. 2008 Sep;70(1):279-88. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.